Relmada Therapeutics Inc. (RLMD)
Relmada Therapeutics Max Pain By Strike
RLMD trades at $2.21, 11.6% below the near-term max pain of $2.5 expiring Oct 17, 2025 (11 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is falling across expirations ($0.5-$7.5), signaling increased put positioning or downside protection. Key magnetic zone at 1 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Relmada Therapeutics Max Pain By Expiry
Max pain for RLMD shows a downward trend from 7.5 to 0.5, indicating bearish sentiment or hedging activity. The 250% spread signals divergent expectations across timeframes. Levels distributed around 2.21. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Oct 17, 2025 | 2.5 | n/a (n/a) |
| Nov 21, 2025 | 0.5 | n/a (n/a) |
| Feb 20, 2026 | 1 | n/a (n/a) |
| May 15, 2026 | 2.5 | n/a (n/a) |
| Dec 18, 2026 | 7.5 | n/a (n/a) |